Study guide
21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
Key Takeaways Explain This Topic AI
The 2023 ASA/ASRA perioperative cannabis guideline recommends screening every patient and delaying elective surgery at least 2 hours after smoked cannabis because of acute tachycardia and airway irritability.
Chronic heavy cannabis use increases propofol and sedation requirements and increases postoperative pain and opioid consumption rather than reducing it.
Cannabidiol inhibits CYP3A4 and CYP2C19 and raises midazolam and fentanyl levels, whereas St. John's wort induces CYP3A4 and lowers cyclosporine, warfarin, and oral contraceptive levels.
Exam-favored herbal discontinuation intervals are ginkgo 36 hours, ephedra and kava 24 hours, garlic and ginseng 7 days, and St. John's wort 5 days, with the ASA recommending 2 to 3 weeks generally.
Cannabinoid hyperemesis syndrome is cyclic vomiting relieved by hot showers that responds poorly to ondansetron and is treated with topical capsaicin, haloperidol or droperidol, and benzodiazepines.
Last updated: August 2026
Why This Topic Matters on the NCE
The NCE content outline lists cannabinoids (I.C.31) and herbal remedies and dietary supplements (I.C.24) as their own pharmacologic classes. Cannabis is now the most commonly used non-prescription psychoactive substance among surgical patients in states where it is legal, and patients frequently do not disclose supplements unless asked directly, because they do not consider them "medications."
- 1. Cannabinoids
- Pharmacology
The cannabis plant contains more than a hundred cannabinoids. Two matter clinically:
Delta-9-tetrahydrocannabinol (THC) is the psychoactive partial agonist at CB1 receptors (central nervous system, presynaptic terminals) and CB2 receptors (immune tissue).
Cannabidiol (CBD) is non-intoxicating but is a potent inhibitor of CYP3A4 and CYP2C19 , which raises concentrations of midazolam, fentanyl congeners, and warfarin.
Smoked or vaporized THC reaches peak plasma concentration within minutes with effects lasting 2 to 4 hours. Oral (edible) THC is absorbed slowly with a delayed peak at 2 to 4 hours and effects that persist 8 to 12 hours or longer, which is why patients frequently underestimate how recently they are still impaired.
Cardiovascular and airway effects
Timing of use Cardiovascular effect Airway/pulmonary effect
Acute intoxication Tachycardia, increased cardiac output, increased myocardial oxygen demand, orthostatic hypotension, conjunctival injection Bronchodilation acutely, but airway irritation from smoke
Heavy chronic use Bradycardia, blunted sympathetic tone, cannabis-associated myocardial infarction and arrhythmia reported Chronic bronchitis, airway hyperreactivity, uvular edema, laryngospasm risk
Anesthetic implications
Increased anesthetic requirement. Chronic heavy users show cross-tolerance, requiring substantially higher propofol induction doses and higher sedation requirements for endoscopy in observational studies.
Increased postoperative pain and opioid consumption , not less, despite the analgesic reputation of cannabis.
Cannabinoid hyperemesis syndrome is cyclic severe vomiting in a chronic heavy user, characteristically relieved by hot showers or baths and poorly responsive to standard antiemetics . It responds to topical capsaicin, haloperidol or droperidol, and benzodiazepines. It is easily mistaken for postoperative nausea and vomiting.
The 2023 ASA/ASRA joint guideline on perioperative cannabis recommends screening every patient for cannabis use, delaying elective surgery for at least 2 hours after smoked cannabis because of the acute cardiovascular and airway effects, counseling patients about greater postoperative pain and opioid requirement, and avoiding delaying urgent surgery for cannabis use alone.
2. Herbal Remedies and Dietary Supplements
The American Society of Anesthesiologists recommends discontinuing herbal medications 2 to 3 weeks before elective surgery . In practice patients rarely do, so the practical task is recognizing the interaction in front of you.
The bleeding group — the "four G's"
- Supplement Mechanism Suggested preoperative discontinuation
- Garlic Irreversible inhibition of platelet aggregation 7 days
- Ginkgo biloba Inhibits platelet-activating factor 36 hours
- Ginseng Inhibits platelet aggregation; also causes hypoglycemia 7 days
- Ginger Inhibits thromboxane synthetase 7 days (variable)
- Vitamin E, fish oil Platelet inhibition 7 days
All of these raise the stakes for neuraxial techniques when combined with each other or with antiplatelet drugs, although current ASRA guidance does not treat herbal supplements alone as a contraindication to neuraxial blockade.
The cardiovascular and sedative group
Ephedra (ma huang) is a direct and indirect sympathomimetic causing hypertension, tachyarrhythmia, myocardial infarction, and stroke. It depletes catecholamines with chronic use, producing intraoperative hypotension refractory to indirect agents. Discontinue at least 24 hours before surgery. Banned as a dietary supplement in the United States since 2004 but still obtainable.
Kava potentiates GABA-A and produces marked sedation with anesthetics and benzodiazepines; it is also hepatotoxic. Discontinue at least 24 hours before surgery.
Valerian is also GABAergic; abrupt cessation can produce a benzodiazepine-like withdrawal syndrome, so it should be tapered rather than stopped, or benzodiazepine cover provided.
St. John's wort is a potent inducer of CYP3A4 and P-glycoprotein, lowering concentrations of cyclosporine, tacrolimus, warfarin, oral contraceptives, protease inhibitors, midazolam, and alfentanil. It also inhibits serotonin reuptake, creating serotonin syndrome risk with meperidine, tramadol, SSRIs, and methylene blue. Discontinue 5 days before surgery.
Echinacea is an immunostimulant that has been associated with allergic reactions and hepatotoxicity with prolonged use; it is best avoided in transplant recipients and other immunosuppressed patients.
Licorice (glycyrrhizin) produces a mineralocorticoid effect: hypertension, hypokalemia, and metabolic alkalosis.
Glucose-lowering supplements
Ginseng, chromium, bitter melon, and fenugreek can cause perioperative hypoglycemia in the fasted patient. Check a glucose on arrival.
Exam Traps
The exam-favored discontinuation intervals are ginkgo 36 hours, ephedra and kava 24 hours, garlic and ginseng 7 days, and St. John's wort 5 days.
St. John's wort induces CYP3A4 ; it does not inhibit it. This is the reverse of CBD, which inhibits CYP3A4.
Cannabis increases anesthetic and analgesic requirements. Expect to need more propofol, not less.
Cyclic vomiting relieved by a hot shower in a chronic cannabis user is cannabinoid hyperemesis syndrome and will not respond to ondansetron alone.